Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate approves measure to limit insurers’ step‑therapy for metastatic cancer; sponsors later successfully move to return the bill to second reading for an am 1
Summary
Senate Bill 422, designed to limit insurers’ step‑therapy requirements for metastatic cancer, passed second reading after emotional floor testimony; later the Senate voted to reconsider and return the bill to second reading so a negotiated amendment may be added.
Senate Bill 422, which would prohibit insurers from imposing certain step‑therapy ("fail first") requirements on patients with metastatic cancer, passed second reading after sponsors and colleagues described personal experiences with serious illness and the bill’s potential to avoid delays in critical treatments.
Sponsor Senator Boldman described her husband’s experience with stage‑3 testicular cancer and framed the bill as protecting patients from insurer practices that delay…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
